Joshua DeTillio insider trades: Nutex Health (NUTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joshua reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2024 | NUTX | ↑ Buy | 1,875 | $17.71 | $33K | Direct | Aug 21, 2024 (1d) |
| Jun 12, 2024 | NUTX | ↑ Buy | 20,000 | $0.54 | $11K | Direct | Jun 13, 2024 (1d) |
| Nov 15, 2023 | NUTX | ↑ Buy | 140,000 | $0.24 | $34K | Direct | Nov 16, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NUTX insiders
Open-market trades in the last 12 months
About Joshua DeTillio's insider trades
Joshua DeTillio is Chief Operating Officer at Nutex Health (NUTX). Since Nov 15, 2023, Joshua has reported 3 open-market purchases worth $78K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (1 filing), option exercises (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.